AzTrials
AzTrials

Low Back PainNCT07568353

Brain Connectivity and Perceptive Surfaces in Chronic Low Back Pain (SUPER-RMNf)

A study testing Perceptive Surface (SU-PER mat) in people with Low Back Pain and Healthy, run by G. d'Annunzio University at 1 site in Italy.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Rationale: Chronic Low Back Pain (CLBP) is often associated with "cortical reorganization," where the brain's map of the back becomes less precise. This phenomenon contributes to the persistence of pain and reduced body awareness. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Low Back Pain, Healthy
What is being tested?
Perceptive Surface (SU-PER mat)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteItaly
Study dates
1 Sep 2026to 1 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged between 18 and 45 years
  • Right-handed dominance
  • Good general health condition
  • Ability to provide written informed consent.
  • For the patient group:
  • Clinical diagnosis of non-specific chronic low back pain with a duration of more than 3 months
  • For the control group:
  • Healthy volunteers without a history of chronic pain

Who cannot join

  • Contraindications to 3T Magnetic Resonance Imaging, such as pacemakers or non-compatible metallic implants
  • Pregnancy or breastfeeding
  • Presence of significant neurological or psychiatric pathologies
  • Current use of psychoactive medications.
  • Sensory or motor disorders of the lower limbs that prevent interaction with the perceptive surface.
  • Unstable or acute clinical conditions.
  • Inability to remain still during the MRI scanning procedure

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site
  • ITAB - Istituto di Tecnologie Avanzate Biomediche - Università degli Studi "G. d'Annunzio"

    Chieti, Chieti (CH), 66100

    Teresa Paolucci, +39 3278588219, teresa.paolucci@unich.it

Other trials in Italy

About this study

Official title: Lombalgia Cronica Aspecifica e Superfici Percettive: Rappresentazione Corticale Del Tronco Nella Risposta al Trattamento Riabilitativo - Studio Quasi-sperimentale Non Randomizzato

Rationale:

Chronic Low Back Pain (CLBP) is often associated with "cortical reorganization," where the brain's map of the back becomes less precise. This phenomenon contributes to the persistence of pain and reduced body awareness. While traditional rehabilitation focuses on the physical structure of the spine, neurocognitive approaches use "perceptive surfaces" to provide specific tactile and proprioceptive feedback, aiming to "retrain" the brain's representation of the trunk.

Read more

Objective and Hypothesis:

The primary goal of this study is to investigate how the brain responds to stimulation from these perceptive surfaces in patients with CLBP compared to healthy individuals. The investigators hypothesize that using these surfaces will lead to immediate changes in functional brain connectivity, particularly in areas responsible for body awareness and pain processing (somatosensory and salience networks).

Study Procedures:

The study will involve 20 patients with chronic non-specific low back pain and 20 healthy volunteers. All participants will undergo a Functional Magnetic Resonance Imaging (fMRI) session. During the scan, participants will be placed on a specialized perceptive surface. Brain activity and connectivity will be measured at rest and during specific tactile stimulation. Additionally, advanced imaging techniques (SANDI model) will be used to look at the microscopic structure of brain cells (neurons).

Clinical Impact:

By comparing the two groups, the study aims to identify specific "brain signatures" of recovery. This could help clinical professionals understand if perceptive surfaces can effectively restore cortical maps, leading to better personalized rehabilitation strategies for chronic pain.

Being tested
Perceptive Surface (SU-PER mat)
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Perceptive Surface (SU-PER mat)Device

    The intervention consists of a postural mat equipped with sensory cones of varying elastic memory and elasticity.

    This tool is used as a neurocognitive rehabilitation device designed to restore body perception and postural control.

    The device is passive, non-magnetic, and made of MRI-compatible latex (inert material).

    During the fMRI session, the surface is positioned so that the participant, while lying in the scanner, perceives specific plantar or trunk tactile and proprioceptive stimuli.

Study groups in NCT07568353
Study groupRoleWhat they receive
CLBP PatientsExperimentalThis arm includes 20 participants with a clinical diagnosis of non-specific chronic low back pain (duration > 3 months). Participants undergo a clinical and functional evaluation through validated scales (VAS, RMDQ, MPQ, Waddell Index, Zung SAS/SDS, BAQ). The experimental procedure consists of a 3T MRI session including two resting-state fMRI blocks: one in a neutral condition and one while interacting with a "perceptive surface" (postural mat with sensory cones). Advanced microstructural imaging (SANDI model) is also performed.
Receives: Device: Perceptive Surface (SU-PER mat)
Healthy ControlsActive comparatorThis arm includes 20 healthy volunteers, aged 18-45, without history of chronic pain. Participants undergo the same 3T MRI protocol as the clinical group (neutral vs. perceptive surface conditions) to provide a baseline for "normal" cortical representation and connectivity. Clinical evaluations for this group are limited to demographic data and the Visual Analogue Scale (VAS) for pain/discomfort monitoring during the scan.
Receives: Device: Perceptive Surface (SU-PER mat)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Connectivity Changes in Somatosensory and Salience Networks

    Measured: Periprocedural

Secondary outcomes (3)
  1. Neuronal Microstructure Mapping (SANDI model)

    Measured: Periprocedural

  2. Acute Pain Perception (Visual Analogue Scale)

    Minimum Value: 0 Maximum Value: 10 Higher scores mean a worse outcome

    Measured: Day 1

  3. Functional Disability in CLBP Patients (Roland Morris Disability Questionnaire)

    Minimum Value: 0 Maximum Value: 24 Higher scores mean a worse outcome

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion1 Dec 2026 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07568353
Sponsor's protocol ID
SUPER-RMNf
Other IDs
447
Status last verified
Jul 2026
First submitted
11 Mar 2026
Last updated
4 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Perceptive Surface (SU-PER mat) in people with Low Back Pain and Healthy, run by G. d'Annunzio University at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Teresa Paolucci (+39 3278588219, teresa.paolucci@unich.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Connectivity Changes in Somatosensory and Salience Networks (time frame: Periprocedural). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in